Coronavirus disease 2019 (COVID-19)

View PDF

Overview 
Theory 
Diagnosis 
Management 
Follow up 
Resources 

This topic is available for free

International guidelines

Rest of the world

Molnupiravir for treating COVID-19[682]

Published by:National Institute for Health and Care Excellence (UK)

Last published:2025

Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19[681]

Published by:National Institute for Health and Care Excellence (UK)

Last published:2025

COVID-19 rapid guideline: managing COVID-19[405]

Published by:National Institute for Health and Care Excellence (UK)

Last published:2025

COVID-19: clinical considerations for special populations[888]

Published by:Centers for Disease Control and Prevention

Last published:2025

Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19[401]

Published by:Infectious Diseases Society of America

Last published:2025

Interim clinical considerations for use of COVID-19 vaccines in the United States[890]

Published by:Centers for Disease Control and Prevention

Last published:2025

CDC yellow book: health information for international travel - COVID-19[889]

Published by:Centers for Disease Control and Prevention

Last published:2025

Therapeutics and COVID-19: living guideline[406]

Published by:World Health Organization

Last published:2025

COVID-19: the green book, chapter 14a[893]

Published by:UK Health Security Agency

Last published:2025

Clinical management of COVID-19: living guideline[444]

Published by:World Health Organization

Last published:2025

COVID-19 treatment clinical care for outpatients[887]

Published by:Centers for Disease Control and Prevention

Last published:2025

COVID-19 outbreak toolbox[892]

Published by:World Health Organization

Last published:2024

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: serologic testing[507]

Published by:Infectious Diseases Society of America

Last published:2024

COVID-19: clinical course - progression, management, and treatment[670]

Published by:Centers for Disease Control and Prevention

Last published:2024

Remdesivir and tixagevimab plus cilgavimab for treating COVID-19[701]

Published by:National Institute for Health and Care Excellence (UK)

Last published:2024

Infection control guidance: SARS-CoV-2[665]

Published by:Centers for Disease Control and Prevention

Last published:2024

Coronavirus (COVID-19): guidance[667]

Published by:UK Health Security Agency

Last published:2024

Overview of testing for SARS-CoV-2[442]

Publicada por:Centers for Disease Control and Prevention

Última publicação:2024

Coronavirus disease 2019 (COVID-19)[894]

Publicada por:Australian Government Department of Health and Aged Care; Australian Centre for Disease Control

Última publicação:2024

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: molecular diagnostic testing[614]

Publicada por:Infectious Diseases Society of America

Última publicação:2023

Drugs to prevent COVID-19: WHO living guideline[404]

Publicada por:World Health Organization

Última publicação:2023

Public health surveillance for COVID-19: interim guidance[124]

Publicada por:World Health Organization

Última publicação:2022 (addendum 2023)

ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2[668]

Publicada por:European Society of Clinical Microbiology and Infectious Diseases

Última publicação:2022

Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing[503]

Publicada por:World Health Organization

Última publicação:2022

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing[615]

Publicada por:Infectious Diseases Society of America

Última publicação:2022

Coronavirus (COVID-19) infection in pregnancy[896]

Publicada por:Royal College of Obstetricians and Gynaecologists (UK)

Última publicação:2022

European Society of Clinical Microbiology and Infectious Diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease[895]

Publicada por:European Society of Clinical Microbiology and Infectious Diseases

Última publicação:2022

Care for adults with COVID-19: living guidelines[897]

Publicada por:Australian National COVID-19 Clinical Evidence Taskforce

Última publicação:2022

Infectious Diseases Society of America guidelines on infection prevention for healthcare personnel caring for patients with suspected or known COVID-19[666]

Publicada por:Infectious Diseases Society of America

Última publicação:2021

Antigen-detection in the diagnosis of SARS-CoV-2 infection: interim guidance[440]

Publicada por:World Health Organization

Última publicação:2021

Surviving Sepsis Campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU[715]

Publicada por:Surviving Sepsis Campaign

Última publicação:2021

Prevention and management of venous thromboembolism in patients with COVID-19[898]

Publicada por:Scottish Intercollegiate Guidelines Network

Última publicação:2021

Management of hospitalised adults with coronavirus disease 2019 (COVID-19)[899]

Publicada por:European Respiratory Society

Última publicação:2021

Diagnostic testing for SARS-CoV-2: interim guidance[439]

Publicada por:World Health Organization

Última publicação:2020

Use of chest imaging in COVID-19: a rapid advice guide[544]

Publicada por:World Health Organization

Última publicação:2020

Home care for patients with suspected or confirmed COVID-19 and management of their contacts: interim guidance[669]

Publicada por:World Health Organization

Última publicação:2020

O uso deste conteúdo está sujeito ao nosso aviso legal

Coronavirus disease 2019 (COVID-19)

International guidelines

Molnupiravir for treating COVID-19[682]National Institute for Health and Care Excellence. Molnupiravir for treating COVID-19. Apr 2025 [internet publication]. https://www.nice.org.uk/guidance/ta1056

Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19[681]National Institute for Health and Care Excellence. Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19. May 2025 [internet publication]. https://www.nice.org.uk/guidance/ta878

COVID-19 rapid guideline: managing COVID-19[405]National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing COVID-19. May 2025 [internet publication]. https://www.nice.org.uk/guidance/ng191

COVID-19: clinical considerations for special populations[888]Centers for Disease Control and Prevention. COVID-19: clinical considerations for special populations. Jun 2025 [internet publication]. https://www.cdc.gov/covid/hcp/clinical-care/considerations-special-groups.html

Therapeutics and COVID-19: living guideline[406]World Health Organization. Therapeutics and COVID-19: living guideline, August 2025. Sep 2025 [internet publication]. https://www.who.int/publications/i/item/B09540

COVID-19: the green book, chapter 14a[893]UK Health Security Agency. COVID-19: the green book, chapter 14a. Sep 2025 [internet publication]. https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a

Clinical management of COVID-19: living guideline[444]World Health Organization. Clinical management of COVID-19: living guideline, June 2025. Jul 2025 [internet publication]. https://www.who.int/publications/i/item/B09467

COVID-19 treatment clinical care for outpatients[887]Centers for Disease Control and Prevention. COVID-19 treatment clinical care for outpatients. Jun 2025 [internet publication]. https://www.cdc.gov/covid/hcp/clinical-care/outpatient-treatment.html

COVID-19 outbreak toolbox[892]World Health Organization. COVID-19 outbreak toolbox. Jul 2024 [internet publication]. https://www.who.int/emergencies/outbreak-toolkit/disease-outbreak-toolboxes/covid-19-outbreak-toolbox

COVID-19: clinical course - progression, management, and treatment[670]Centers for Disease Control and Prevention. COVID-19: clinical course - progression, management, and treatment. Jun 2024 [internet publication]. https://www.cdc.gov/covid/hcp/clinical-care/management-and-treatment.html

Remdesivir and tixagevimab plus cilgavimab for treating COVID-19[701]National Institute for Health and Care Excellence. Remdesivir and tixagevimab plus cilgavimab for treating COVID-19. May 2024 [internet publication]. https://www.nice.org.uk/guidance/ta971

Infection control guidance: SARS-CoV-2[665]Centers for Disease Control and Prevention. Infection control guidance: SARS-CoV-2. Jun 2024 [internet publication]. https://www.cdc.gov/covid/hcp/infection-control/index.html

Coronavirus (COVID-19): guidance[667]UK Health Security Agency. Coronavirus (COVID-19): guidance. Feb 2024 [internet publication]. https://www.gov.uk/government/collections/coronavirus-covid-19-list-of-guidance

Overview of testing for SARS-CoV-2[442]Centers for Disease Control and Prevention. Overview of testing for SARS-CoV-2. Aug 2024 [internet publication]. https://www.cdc.gov/covid/hcp/clinical-care/overview-testing-sars-cov-2.html

Drugs to prevent COVID-19: WHO living guideline[404]World Health Organization. Drugs to prevent COVID-19: living guideline. Mar 2023 [internet publication]. https://www.who.int/publications/i/item/WHO-2019-nCoV-prophylaxes-2023.1

Public health surveillance for COVID-19: interim guidance[124]World Health Organization. Public health surveillance for COVID-19: interim guidance. Jul 2022 (addendum Aug 2023) [internet publication]. https://www.who.int/publications/i/item/WHO-2019-nCoV-SurveillanceGuidance-2022.2

Diagnostic testing for SARS-CoV-2: interim guidance[439]World Health Organization. Diagnostic testing for SARS-CoV-2: interim guidance. Sep 2020 [internet publication]. https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2

Use of chest imaging in COVID-19: a rapid advice guide[544]World Health Organization. Use of chest imaging in COVID-19: a rapid advice guide, 11 June 2020. Jun 2020 [internet publication]. https://www.who.int/publications/i/item/use-of-chest-imaging-in-covid-19

Conectar-se ou assinar para acessar todo o BMJ Best Practice

Conectar-se ou assinar para acessar todo o BMJ Best Practice

Conectar-se para acessar todo o BMJ Best Practice

Molnupiravir for treating COVID-19[682]

Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19[681]

COVID-19 rapid guideline: managing COVID-19[405]

COVID-19: clinical considerations for special populations[888]

Therapeutics and COVID-19: living guideline[406]

COVID-19: the green book, chapter 14a[893]

Clinical management of COVID-19: living guideline[444]

COVID-19 treatment clinical care for outpatients[887]

COVID-19 outbreak toolbox[892]

COVID-19: clinical course - progression, management, and treatment[670]

Remdesivir and tixagevimab plus cilgavimab for treating COVID-19[701]

Infection control guidance: SARS-CoV-2[665]

Coronavirus (COVID-19): guidance[667]

Overview of testing for SARS-CoV-2[442]

Drugs to prevent COVID-19: WHO living guideline[404]

Public health surveillance for COVID-19: interim guidance[124]

Diagnostic testing for SARS-CoV-2: interim guidance[439]

Use of chest imaging in COVID-19: a rapid advice guide[544]